Summary Human bone marrow-derived mesenchymal stem cells (MSCs) have emerged as a promising tool for clinical applications, which require developing techniques and protocols of cell expansion to overcome cell senescence, loss of pluripotent gene expression, decrease in self-renewal and differentiation potential, low engraftment after in vivo transplantation, and rejection by allogeneic recipients. Moreover, the expanded cells should have normal karyotype and genome integrity to prevent tumorigenic transformation. Cultivation of MSCs under hypoxic conditions, the normal physiologic status of bone marrow, represents a new platform of MSC expansion for clinical applications. This article reviews the effects of hypoxic culture on MSCs, especially for translation from bench to bedside, emphasizing hypoxia as an important factor in all of the major aspects of MSC biology.
Introduction
Mesenchymal stem cells (MSCs) are the best studied subpopulations of stem/progenitor cells in bone marrow capable of differentiating into various nonhematopoietic cells, and they are isolated by their adherence to tissue culture surfaces.
1e4 They are readily isolated from patients, they can be expanded in culture with maintained differentiation potential and immune-modulating properties, and they have a limited tendency to form tumors. Thus, MSCs have emerged as a promising tool for clinical applications such as tissue engineering and cell-based therapy. The first stem cell drug in the world has just been approved in Canada to treat acute graft-versus-host disease in allogeneic recipients.
Criteria for defining human MSCs
Because the therapeutic potential of MSCs has generated remarkably increasing interest in a wide variety of biomedical disciplines and because of the increasing difficulties to compare outcomes, the International Society for Cellular Therapy has proposed minimal criteria to define human MSCs. Thus, MSCs expanded for clinical applications should meet all of the criteria. 5 Firstly, MSCs must be adherent to plastic when maintained in standard culture conditions. Secondly, MSCs must express CD105, CD73, and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD79-alpha or CD19, and human leukocyte antigen (HLA)-DR surface molecules. Thirdly, MSCs must possess the ability to differentiate into osteoblasts, adipocytes, and chondroblasts in vitro.
Problems encountered during clinical application
There are several problems associated with the clinical application of MSCs (Table 1) . For clinical applications, these cells should be expanded to a large scale with a goldstandard protocol without undergoing senescence or loss of proliferation capacity. Moreover, the expanded cells should meet the criteria for MSCs, maintain the expression of pluripotency genes and the potential for differentiation, and engraft or regenerate the tissues following transplantation into autologous or allogeneic recipients. Since MSC-derived microvesicles have been proposed to protect patients against injuries, such as renal injury in the mouse remnant kidney model, 6 the real roles of MSCs in contributing therapeutic effects in injuries should be clarified prior to clinical application. More importantly, the processing procedures or the facility used for cell manipulation or expansion should be regulated and approved to provide products that pass tests regarding identity, potency, purity, and safety of cell products [United States Pharmacopeia 32 (1046)].
Hypoxic niche
The bone marrow niche facilitates the maintenance of hematopoietic stem cells (HSCs) as undifferentiated while supporting the lineage commitment of the expanding blood populations. 7 MSCs that reside in the bone marrow, are associated with and maintain HSCs functions, give rise to mesenchymal-committed cells such as osteoblasts and adipocytes for maintaining bone structures. Bone marrow is hypoxic and has an oxygen tension around 1e7%. 8, 9 Because the general culture condition of 21% oxygen within an incubator is hyperoxic compared with the normal niche of MSCs, one of the strategies to solve the problems encountered upon clinical application of MSCs is expanding these cells under hypoxic conditions. Thus, the roles of the bone marrow niche in maintaining MSC properties and functions should be well investigated. To understand the effects of the marrow niche on MSC properties and functions, we and other groups 10, 11 cultured MSCs under hypoxic conditions and compared them with those cultured under normoxic conditions. Most studies have demonstrated that MSCs cultured under hypoxia or absolute hypoxia fulfill the criteria for defining MSCs 5 without undergoing apoptosis or changing immunophenotypes. 10, 11 This article discusses the effects of hypoxic culture on the properties of MSCs, especially for translation from bench to bedside.
Effects of hypoxic culture on expansion and life span
The effects of hypoxic culture on MSC proliferation and expansion efficiency depend on the sources of derived MSCs, the oxygen concentration, the seeding density, and the duration used to culture the MSCs. Some studies have found that hypoxia significantly inhibits proliferation, 12e16 and others have found that hypoxia increases the proliferation capacity or increases their life span. 10,16e22 We demonstrated that the effect of hypoxia on proliferation was inhibited within one passage of culture either at low-density (10e200 cells/cm 2 ) or at high density (1000e4000 cells/ cm 2 ), 13 whereas hypoxia significantly increased the expansion efficiency on long-term expansion ( 60 days) of MSCs at low density. 23 Moreover, hypoxia also inhibited senescence, increased proliferation, and enhanced in vitro and in vivo differentiation potential. 23 The results of these studies show that the effects of hypoxia on short-term MSC proliferation varied and depended on the oxygen tensions, seeding densities, and MSC sources used. However, the beneficial effects of hypoxia on the long-term expansion of MSCs are consistent even with different MSC sources at a variety of oxygen concentrations. 10, 21, 23 6. Effects of hypoxic culture on maintaining self-renewal and potential differentiation Stem cell properties, referred to as self-renewal and differentiation potential, are prerequisites for success in stem cell applications. Low-density culture under normoxic conditions provides a method for rapid expansion of MSCs 24 with the loss of proliferation capacity and the gain of cell senescence. 23, 25 Furthermore, the long-term expansion of MSCs under normoxic conditions adversely affects stem-cell function when protecting the myocardium. 26 By contrast, low-density culture combined with hypoxic culture maintains proliferation as well as potential differentiation, it increases the expression of pluripotent genes, such as Oct4, Nanog, and Sox2, 27 and it inhibits senescence. 23 Similarly, MSCs with hypoxic preconditioning have been shown to increase in the lineage differentiation into bone, 28 fat, and cartilage 29 both in vitro and in vivo. 23 Increased telomere length and telomerase activity, normal karyotyping, and chromosome integration have also been observed. 23 Moreover, MSCs with long-term hypoxic preconditioning do not form tumors when transplanted into immunodeficient mice, suggesting that hypoxic culture provides a method for efficiently expanding MSCs without losing stemness 27, 30 or increasing tumorigenicity.
Effects of hypoxic culture on engraftment
The ability of stem or progenitor cells to home and engraft into target tissues after transplantation is the key to succeed in clinical application. The degree of homing and engraftment of MSCs adult recipients is very low. Interestingly, it has been demonstrated that a 1-day exposure of MSCs to 1% oxygen increased in vitro migration and in vivo engraftment via the increase of CX3C chemokine receptor 1 (CX3CR1)-fractalkine and CXC chemokine receptor4-stromal derived factor-1 (CXCR4-SDF-1)-alpha interaction. 13 MSCs cultured under hypoxic conditions also increased in vascular endothelial growth factor receptor 1 (VEGFR1) expression and VEGF-or placental growth factor (PLGF)-dependent migration. 34 Preconditioning with oxygen and combined glucose depletion also increased the survival of stem cell antigen (Sca)-1þ cells via phosphatidylinositol 3-OH kinase (PI3K)/Protein kinase B (also known as Akt)-dependent caspase-3 downregulation and thereby increased the engraftment rate. 35 In addition to the increase in migration and survival, MSCs with hypoxic preconditioning have also been shown to enhance revascularization after transplantation for hind limb ischemia. 36 These results suggest that short-term hypoxic preconditioning of MSCs may provide a general method of enhancing their survival, migration, angiogenesis, and engraftment in vivo into a variety of tissues.
Effects of hypoxic culture on allogeneic transplantation
Use of MSCs from healthy donors as an "off-the-shelf" product has proven safe in two Phase III studies in patients with graft-versus-host disease and Crohn's disease (http:// www.clinicaltrails.gov/). Moreover, allogeneic MSCs were also reported to improve ejection fractions in patients with acute myocardial infarction. 37 The immunosuppressive features of human, baboon, and murine MSCs were also reported in vitro, 38e41 in vivo, 41 and attenuating graftversus-host disease in humans. 42 However, many studies have demonstrated allogeneic MSCs were rejected in immunocompetent MHC-mismatched recipients. 43e45 Thus, the use of MSCs for allogeneic transplantation remains controversial. Thus, identifying methods for enhancing immunoprivilege in MSCs can help these cells serve as a "universal donor cell" for treating diseases. A previous study demonstrated that allogeneic hypoxic MSCs increase the therapeutic effects in bone defect repair compared with allogeneic normoxic MSCs. 46 These results suggest that hypoxic MSCs are intrinsically immunoprivileged and can serve as a "universal donor cell" for treating diseases.
Conclusion
Altogether, the studies currently available suggest that hypoxic cultures have multiple effects on MSCs, which affect short-term proliferation, long-term expansion efficiency, differentiation potential, stemness or maintenance of stem cell properties, the expression of chemokine receptors, migration, and engraftment ability. Moreover, MSCs can survive and engraft in allogeneic recipients. The platform based on hypoxic culture will help develop strategies for clinical applications of MSCs.
